New drug S-740792 tested in healthy volunteers for first time

NCT ID NCT06724978

Completed Knowledge-focused Sponsor: Shionogi Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-phase trial tested the safety and processing of a new drug called S-740792 in 99 healthy adults. Participants received single or multiple doses of the drug as a liquid or tablet, and some received a placebo. The goal was to gather safety data and understand how the body handles the drug, which is a necessary step before testing it in patients with a disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: S-740792 (oral suspension and tablet)
What this could lead to: If successful, this study could provide safety data needed to test S-740792 in patients with a specific disease in the future.
What could go wrong: This is a very early Phase 1 trial in healthy people, not patients. It only checks safety and how the drug moves through the body, not whether it treats any disease. Many drugs fail in later stages.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY PARTICIPANTS

Contacts and locations

Locations

Fortrea Clinical Research Unit, Inc.

Daytona Beach, Florida, 32117, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.